Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-25341
Publication type: Article in scientific journal
Type of review: Peer review (publication)
Title: Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data
Authors: Höglinger, Marc
Wirth, Brigitte
Carlander, Maria
Caviglia, Cornelia
Frei, Christian
Rhomberg, Birgitta
Rohrbasser, Adrian
Trottmann, Maria
Eichler, Klaus
et. al: No
DOI: 10.1007/s10198-022-01486-2
10.21256/zhaw-25341
Published in: The European Journal of Health Economics
Issue Date: 18-Jun-2022
Publisher / Ed. Institution: Springer
ISSN: 1618-7601
1618-7598
Language: English
Subjects: Diabetes; Disease management; Primary care; Program evaluation; Quality of care; Structured treatment program
Subject (DDC): 362.1041: Health economics
616: Internal medicine and diseases
Abstract: Objective: To evaluate the impact of a DMP for patients with diabetes mellitus in a Swiss primary care setting. Methods: In a prospective observational study, we compared diabetes patients in a DMP (intervention group; N?=?538) with diabetes patients receiving usual care (control group; N?=?5050) using propensity score matching with entropy balancing. Using a difference-in-difference (DiD) approach, we compared changes in outcomes from baseline (2017) to 1-year (2017/18) and to 2-year follow-up (2017/19). Outcomes included four measures for guideline-adherent diabetes care, hospitalization risk, and health care costs. Results: We identified a positive impact of the DMP on the share of patients fulfilling all measures for guideline-adherent care [DiD 2017/18: 7.2 percentage-points, p?<?0.01; 2017/19: 8.4 percentage-points, p?<?0.001]. The hospitalization risk was lower in the intervention group in both years, but only statistically significant in the 1-year follow-up [DiD 2017/18: – 5.7 percentage-points, p?<?0.05; 2017/19: – 3.9 percentage points, n.s.]. The increase in health care costs was smaller in the intervention than in the control group [DiD 2017/18: CHF – 852; 2017/19: CHF – 909], but this effect was not statistically significant. Conclusion: The DMP under evaluation seems to exert a positive impact on the quality of diabetes care, reflected in the increase in the measures for guideline-adherent care and in a reduction of the hospitalization risk in the intervention group. It also might reduce health care costs, but only a longer follow-up will show whether the observed effect persists over time.
URI: https://digitalcollection.zhaw.ch/handle/11475/25341
Fulltext version: Published version
License (according to publishing contract): CC BY 4.0: Attribution 4.0 International
Departement: School of Management and Law
Organisational Unit: Winterthur Institute of Health Economics (WIG)
Appears in collections:Publikationen School of Management and Law

Files in This Item:
File Description SizeFormat 
2022_Hoeglinger-etal_Impact-diabetes-disease-management.pdf551.4 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.